5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol
C24H23F6N3O2S — CID 123566242
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol
5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol (PubChem CID 123566242) has the molecular formula C24H23F6N3O2S and a molecular weight of 531.52 g/mol. Its IUPAC name is 5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol.
Molecular Properties
| Compound Name | 5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol |
|---|---|
| PubChem CID | 123566242 |
| Molecular Formula | C24H23F6N3O2S |
| Molecular Weight | 531.52 g/mol |
| Exact Mass | 531.14 |
| IUPAC Name | 5-[[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]phenyl]methyl]-2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-ol |
| SMILES | CN1CCN(c2nc(O)c(Cc3ccc(OCc4ccc(C(F)(F)F)cc4C(F)(F)F)cc3)s2)CC1 |
| InChI | InChI=1S/C24H23F6N3O2S/c1-32-8-10-33(11-9-32)22-31-21(34)20(36-22)12-15-2-6-18(7-3-15)35-14-16-4-5-17(23(25,26)27)13-19(16)24(28,29)30/h2-7,13,34H,8-12,14H2,1H3 |
| InChIKey | HPEPLPRFGARKHX-UHFFFAOYSA-N |
| XLogP | 5.81 |
| TPSA | 48.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 531.52 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123566242 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.